Area of research
Cancer Research · Genetics
Research interest
Research focused on Mesenchymal stem cell and Cancer research, with related work in Inflammatory bowel disease, Monoclonal antibody, Hepatocellular carcinoma. Notable publications include 'miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation', 'YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression', and 'Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice'.
Metabolic-associated fatty liver disease (MAFLD) promotes the progression of hepatocellular carcinoma by enhancing KIF20A expression
HucMSC-Ex alleviates inflammatory bowel disease by regulating O-GlcNAcylation modification of RACK1 in intestinal epithelial cells
Emerging role of mesenchymal stem cell-derived exosomes in the repair of acute kidney injury
PLGA-hucMSC-Ex Ameliorates Colitis by Reversing Epithelial-mesenchymal Transition
Generation and characterization of a IgG monoclonal antibody specific for GM3 (NeuGc) ganglioside by immunizing β3Gn-T5 knockout mice
YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression
miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation